SCHEMBL18626464

SCHEMBL18626464

N#CCC[C@H](C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)c1cnn[nH]1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MME P08473 20/20 0.50
ACE P12821 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16930519 0.91 MME (0.52) MMEACE
SCHEMBL18874766 0.90 MME (0.50) MME
SCHEMBL11969680 0.86 MME (0.63) MMEACE
SCHEMBL11969711 0.86 MME (0.63) MMEACE
SCHEMBL20306292 0.86 MME (0.52) MMEACE
SCHEMBL16930538 0.84 MME (0.53) MMEACE
SCHEMBL16939268 0.83 MME (0.49) MME
SCHEMBL9929979 0.82 MME (0.72) MME
SCHEMBL16939263 0.82 MME (0.52) MME
SCHEMBL11969549 0.80 MME (0.55) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9593110-B2 Neprilysin inhibitors Theravence Biopharma R&D IP, LLC (US) 2017-03-14 US disclosed